CEACAM5 and familial pancreatic carcinoma: This renders CEA a useful diagnostic biomarker, as serum detection can serve to identify cancer development for several cancer types including breast [201–203], skin cancer [204], NSCLC [205–207], gastric [202, 208–211], and pancreatic cancer [202, 212–215].